| Literature DB >> 29903854 |
Nicole C Lockhart1, Carol J Weil2, Latarsha J Carithers3, Susan E Koester4, A Roger Little5, Simona Volpi6, Helen M Moore2, Benjamin E Berkman7.
Abstract
The active debate about the return of incidental or secondary findings in research has primarily focused on return to research participants, or in some cases, family members. Particular attention has been paid to return of genomic findings. Yet, research may generate other types of findings that warrant consideration for return, including findings related to the pathology of donated biospecimens. In the case of deceased biospecimen donors who are also organ and/or tissue transplant donors, pathology incidental findings may be relevant not to family members, but to potential organ or tissue transplant recipients. This paper will describe the ethical implications of pathology incidental findings in the Genotype-Tissue Expression (GTEx) project, the process for developing a consensus approach as to if/when such findings should be returned, possible implications for other research projects collecting postmortem tissues and how the scenario encountered in GTEx fits into the larger return of results/incidental findings debate. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: clinical ethics; donation/procurement of organs/tissues; human tissue; pathology; research ethics
Mesh:
Year: 2018 PMID: 29903854 PMCID: PMC6740237 DOI: 10.1136/medethics-2017-104691
Source DB: PubMed Journal: J Med Ethics ISSN: 0306-6800 Impact factor: 2.903